Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
PaperCitations, authors & open-access status
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,850 citations, 2017 year and green oa status.
2,850
Citations
2017
Year
green
OA Status